A daily dose of aspirin may help reduce the risk of serious
complications from COVID-19. That’s according to researchers from the University of Maryland School of Medicine.
The researchers examined the records of 412 adults with COVID-19 who were admitted to hospitals across the United States between March and July. Slightly more than 23 percent of the people who were studied were given a daily low dose of aspirin within 24 hours of their admission to the hospital or in the 7 days prior to their admission.
The researchers reported that people taking aspirin were 44 percent less likely to be put on a ventilator and 43 percent less likely to be admitted to the intensive care unit (ICU). The researchers also reported that those who took aspirin had a 47 percent decrease in risk of dying from COVID-19 when compared with those studied who were not taking a daily dose of aspirin.
No comments:
Post a Comment